2016 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

News

 

Getinge Group and GE Launch Angiography Integrated Solution for Hybrid OR Procedures

August 25, 2016 -- Getinge Group announced the launch of a new, highly flexible angiography solution for surgery, interventional, and hybrid operating room (OR) procedures in …

SVS Announces New Reporting Standards for Thoracic Outlet Syndrome

August 23, 2016 -- The Society for Vascular Surgery (SVS) announced the publication of new reporting standards for thoracic outlet syndrome (TOS) by Karl A. Illig, MD, et al i…

FDA Clears Bio2 Medical’s Angel Catheter Including Prophylactic Indication for Pulmonary Embolism

August 24, 2016 -- Bio2 Medical Inc. announced that the Angel catheter has received US Food & Drug Administration (FDA) 510(k) clearance, which includes a prophylactic ind…

FDA and Industry Groups Announce Tentative Accord to Reauthorize Medical Device User Fee Agreement

August 24, 2016 -- The US Food and Drug Administration (FDA) announced that it has reached an agreement in principle with representatives from the medical device industry and …

English Study Finds Women Have Increased Mortality and Morbidity After AAA Repair

August 24, 2016 -- In a study conducted to quantify the difference in long-term survival and cardiovascular morbidity between women and men undergoing elective abdominal aorti…

European Studies Evaluate Carotid Artery Stenting Devices

August 23, 2016 -- Two studies of carotid artery stenting were published online in EuroIntervention. Marc Bosiers, MD, et al reported findings from the CLEAR-ROAD study (…

Click here for more News coverage

Current Supplements

Sponsored by GORE & ASSOCIATES

Value-Based Decisions for Dialysis Access

How practitioners of dialysis access creation and intervention are improving patient outcomes while reducing system costs.

Summer Supplement

Sponsored by Medtronic

Uncomplicating EVAR

Experts share how EndoAnchors are empowering physicians and aortic centers with unparalleled capabilities in the treatment of patients with aortic disease.

Current European Supplement

Sponsored by Spectranetics

Evidence From the Next-Generation DCB

More With Less

Featured Center

 

Embolization

advertisement

 
Vascular Market Price  Change
Abbott Laboratories $42.98  0.33%
AstraZeneca PLC $33.05  -0.54%
Avinger $4.10  -1.91%
Boston Scientific Corporation $23.97  0.84%
Cardinal Health $79.35  -0.01%
Cardiovascular Systems Inc. $24.54  2.98%
CR Bard Inc. $217.07  0.81%
Edwards Lifesciences Corp. $115.26  0.43%
Endologix Inc. $11.63  0.69%
Johnson and Johnson $119.04  0.40%
Vascular Market Price  Change
Lombard Medical, Inc. $0.89  -1.11%
Medtronic, Inc. $86.60  1.42%
Merit Medical Systems, Inc. $23.56  0.51%
Penumbra, Inc. $71.77  1.26%
St. Jude Medical Inc. $78.01  0.24%
Stryker $114.44  1.00%
The Medicines Company $39.81  2.58%
The Spectranetics Corporation $24.95  1.13%
Vascular Solutions Inc. $47.74  1.17%

@EVToday

Stay current: Follow Endovascular Today on Twitter @EVToday

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.